Janani Sundaresan

838 total citations
12 papers, 445 citations indexed

About

Janani Sundaresan is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Janani Sundaresan has authored 12 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in Janani Sundaresan's work include interferon and immune responses (2 papers), Chromatin Remodeling and Cancer (2 papers) and RNA modifications and cancer (2 papers). Janani Sundaresan is often cited by papers focused on interferon and immune responses (2 papers), Chromatin Remodeling and Cancer (2 papers) and RNA modifications and cancer (2 papers). Janani Sundaresan collaborates with scholars based in United States, Singapore and Netherlands. Janani Sundaresan's co-authors include Vikas Madan, H. Phillip Koeffler, Yves Lutz, Michael Schilling, Ludovic Collin, Roberto Villaseñor, Seishi Ogawa, Aiko Sato‐Otsubo, Henry Yang and Deepika Kanojia and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Janani Sundaresan

12 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janani Sundaresan United States 7 293 83 61 58 43 12 445
Ying Xia China 9 285 1.0× 60 0.7× 34 0.6× 82 1.4× 34 0.8× 20 434
Yinyan Xu China 10 191 0.7× 108 1.3× 44 0.7× 64 1.1× 88 2.0× 31 382
Marco T. Birke Germany 17 547 1.9× 146 1.8× 39 0.6× 39 0.7× 26 0.6× 19 845
Andrew S. Gilder United States 13 276 0.9× 48 0.6× 121 2.0× 147 2.5× 53 1.2× 16 517
Andrea Horvat Sweden 6 160 0.5× 75 0.9× 74 1.2× 36 0.6× 25 0.6× 6 446
José Gabriel Barcia Durán United States 8 242 0.8× 60 0.7× 79 1.3× 23 0.4× 28 0.7× 18 434
Seyedmehdi Shojaee United States 7 240 0.8× 62 0.7× 37 0.6× 56 1.0× 28 0.7× 13 508
Tshering Lama-Sherpa United States 12 374 1.3× 56 0.7× 90 1.5× 69 1.2× 25 0.6× 22 527
Lynn Greenhalgh United Kingdom 8 226 0.8× 61 0.7× 45 0.7× 33 0.6× 62 1.4× 11 507
Carol B. Martin United States 10 224 0.8× 51 0.6× 90 1.5× 46 0.8× 38 0.9× 12 384

Countries citing papers authored by Janani Sundaresan

Since Specialization
Citations

This map shows the geographic impact of Janani Sundaresan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janani Sundaresan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janani Sundaresan more than expected).

Fields of papers citing papers by Janani Sundaresan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janani Sundaresan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janani Sundaresan. The network helps show where Janani Sundaresan may publish in the future.

Co-authorship network of co-authors of Janani Sundaresan

This figure shows the co-authorship network connecting the top 25 collaborators of Janani Sundaresan. A scholar is included among the top collaborators of Janani Sundaresan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janani Sundaresan. Janani Sundaresan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sundaresan, Janani, Gerrit Jansen, Eduard A. Struys, et al.. (2024). Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non‐target red blood cells of patients with Crohn's disease. Basic & Clinical Pharmacology & Toxicology. 135(3). 308–320. 2 indexed citations
2.
Fidder, Herma H., Bas Oldenburg, Janani Sundaresan, et al.. (2023). Therapeutic drug monitoring of methotrexate in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 58(11-12). 1151–1162. 13 indexed citations
3.
Bonás, Montse Janssen, Janani Sundaresan, Ruth G.M. Keijsers, et al.. (2023). Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study. Lung. 201(6). 617–624. 2 indexed citations
4.
Sundaresan, Janani, Alessandro Leonetti, Marcello Tiseo, et al.. (2021). Hype or hope – Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC?. Critical Reviews in Oncology/Hematology. 166. 103454–103454. 20 indexed citations
5.
Toker, Lilah, Gia Tuong Tran, Janani Sundaresan, et al.. (2021). Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain. Molecular Neurodegeneration. 16(1). 31–31. 84 indexed citations
6.
Griner, Lesley A. Mathews, Janani Sundaresan, Zhiya Yu, et al.. (2020). Identification of Small Molecule Enhancers of Immunotherapy for Melanoma. Scientific Reports. 10(1). 5688–5688. 6 indexed citations
7.
Han, Lin, Vikas Madan, Anand Mayakonda, et al.. (2019). Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice. Leukemia. 33(9). 2291–2305. 47 indexed citations
8.
Arjunaraja, Swadhinya, Jeffrey R. Stinson, Batsukh Dorjbal, et al.. (2018). A Unique Heterozygous CARD11 Mutation Combines Pathogenic Features of Both Gain- and Loss-of-Function Patients in a Four-Generation Family. Frontiers in Immunology. 9. 2944–2944. 21 indexed citations
9.
Han, Lin, Vikas Madan, Anand Mayakonda, et al.. (2018). ARID1A Is Critical for Maintaining Normal Hematopoiesis in Mice. Blood. 132(Supplement 1). 3833–3833. 3 indexed citations
10.
Villaseñor, Roberto, Michael Schilling, Janani Sundaresan, Yves Lutz, & Ludovic Collin. (2017). Sorting Tubules Regulate Blood-Brain Barrier Transcytosis. Cell Reports. 21(11). 3256–3270. 71 indexed citations
11.
Madan, Vikas, Deepika Kanojia, Jia Li, et al.. (2015). Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nature Communications. 6(1). 6042–6042. 173 indexed citations
12.
Madan, Vikas, Deepika Kanojia, Jia Li, et al.. (2014). ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS. Blood. 124(21). 4609–4609. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying Xia Breakdown of academic impact, for papers by Yinyan Xu Breakdown of academic impact, for papers by Marco T. Birke Breakdown of academic impact, for papers by Andrew S. Gilder Breakdown of academic impact, for papers by Andrea Horvat Breakdown of academic impact, for papers by José Gabriel Barcia Durán Breakdown of academic impact, for papers by Seyedmehdi Shojaee Breakdown of academic impact, for papers by Tshering Lama-Sherpa Breakdown of academic impact, for papers by Lynn Greenhalgh Breakdown of academic impact, for papers by Carol B. Martin
Rankless by CCL
2026